LSA
PROF

Leonteq Securities AG’s Profound Medical PROF Stock Holding History

Leonteq Securities AG’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,500
Closed -$30.3K – 1202
2021
Q2 		$30.3K Buy
1,500
+100
+7% +$1.86K ﹤0.01% 895
2021
Q1 		$35.3K Buy
+1,400
New +$33.6K ﹤0.01% 820

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Leonteq Securities AG's PROF Position: Q3 2021 in Review

Leonteq Securities AG sold out of Profound Medical (PROF) in Q3 2021, closing a stake of 1,500 shares — an estimated $30.3K sold.

Leonteq Securities AG first reported a position in PROF in Q1 2021 and held it in 2 quarters. The position peaked at $35.3K in Q1 2021. 46 funds tracked by Wall St. Rank hold PROF as of Q3 2021.

  • Leonteq Securities AG reported no remaining Profound Medical position as of Q3 2021 after selling out during the quarter.
  • Leonteq Securities AG sold 1,500 Profound Medical shares in Q3 2021, an estimated $30.3K.
  • Leonteq Securities AG first reported a position in Profound Medical in Q1 2021 and held it in 2 quarters.
  • Leonteq Securities AG's Profound Medical position peaked at $35.3K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Profound Medical as of Q3 2021.

Based on Leonteq Securities AG's 13F filing for Q3 2021, filed 26 Mar 2026.